Filed with the SEC on · accession 0001193125-26-451932
INO filed a 424B5 (prospectus (offering)) with the SEC on Nov 6, 2026. INOVIO Pharmaceuticals is offering 58,747,235 shares of common stock at $1.05 per share and pre-funded warrants to purchase 12,681,337 shares at $1.049 per warrant, raising approximately $75 million in gross proceeds. The stock moved -16.2% by the first close after the filing.
INOVIO Pharmaceuticals is offering 58,747,235 shares of common stock at $1.05 per share and pre-funded warrants to purchase 12,681,337 shares at $1.049 per warrant, raising approximately $75 million in gross proceeds. The offering is expected to close on or about November 9, 2026.
Close before
$1.45
Nov 5, 2026
First close after
-16.21%
$1.22
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for INO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INO?
Click hereINO filed a 424B5 (Secondary offering). INOVIO Pharmaceuticals is offering 58,747,235 shares of common stock at $1.05 per share and pre-funded warrants to purchase 12,681,337 shares at $1.049 per warrant, raising approximately $75 million in gross proceeds. The offering is expected to close on or about November 9, 2026.
New shares dilute existing holders and are often sold at a discount to the market price.
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
INO closed at $1.45 before the filing and $1.22 on Nov 6, 2026 (-16.21%).
Get alerts when INO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days